Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35

United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net buying

Bought (12 mo)

$350.00M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$16.50M

$933.83K on a plan · $8.93M straight out of an exercise

Sold at will

$6.64M

47 of 62 sales

Net

+$333.50M

+$343.36M against sales at will